ERDERA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,253 results for “ERDERA”

Trials

View all 2078 →

Topical Cyclosporine and Disease Progression

80 participants · First posted Dec 5, 2007

Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease

100 participants · First posted Dec 6, 2013

Oasys vs. Extreme H20 Xtra 59

52 participants · First posted May 24, 2007

Drugs

View all 24 →

ERDRP-0519

OXM (Entera Bio)

TLR modulators (Idera)

Organizations

View all 14 →

Verdera Energy Corp

United States

Gerbera Therapeutics, Inc.

United States

Embera Neurotherapeutics, Inc.

United States

News

View all 137 →

Fondazione Telethon to Lead €30 Million ERDERA Call for Rare Disease Clinical Trials

Ardena Completes Divestment of Swedish API Manufacturing Site to Nanologica

Genentech and Roche Secure UPC Evidence Orders Against Organon's Pertuzumab Biosimilar

Page 1 of 226